AI-generated summary
The authors randomized 66 patients with mild to moderate carpal tunnel syndrome to gallium-aluminum-arsenide laser therapy or placebo laser, both with a neutral wrist splint, and report 59 completed the study. They report greater improvement in the laser group, especially in grip strength and median nerve distal motor latency at 12 weeks. The authors conclude the therapy is effective, though the abstract's own conclusion is stated more strongly than the reported results warrant.
- Participants
- 59
- Who or what was studied
- Patients with mild to moderate carpal tunnel syndrome (66 randomized, 59 completed, 112 hands)
- Limits stated in the abstract
- The abstract reports 66 randomized but 59 completed, and does not state a wavelength for the laser used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 18 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.